TLPH
TALPHERA, INC.
Key Financials
Revenue
$475000
↓ 21.9%
Net Income
$-14290000
↓ 9.9%
Operating Income
$-13484000
↑ 11.6%
EPS (Diluted)
$-1.29
↓ 122.6%
Shareholders' Equity
$17.0M
↑ 112.9%
Total Liabilities
$12.7M
↑ 23.9%
Cash & Equivalents
$5.9M
↓ 33.5%
Total Assets
$29.7M
↑ 63.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 8/12/2026 | View on SEC |
| 10-Q | 8/12/2026 | View on SEC |
| 8-K | 8/12/2026 | View on SEC |
| SCHEDULE 13G/A | 8/12/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
| 4 | 6/24/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TLPH |
| Company Name | TALPHERA, INC. |
| CIK | 1427925 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 650-216-3500 |